Latest News and Press Releases
Want to stay updated on the latest news?
-
Initial data from ongoing Phase 1/2 trial in patients with second and third line PDAC treated with vopimetostat and daraxonrasib showed 6-month PFS rate of 90% (median PFS not yet reached) suggesting...
-
YieldMax ETFs Announces Distributions on MSST, NVIT, and TEST
-
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 08, 2026 (GLOBE NEWSWIRE) -- SPARC AI Inc. (the...
-
Board Urges Shareholders to Vote FOR ALL of Genco’s Highly Qualified and Experienced Directors on the WHITE Proxy Card TODAY — and WITHHOLD on Diana’s Nominees in Line with All Three Independent Proxy...
-
Red White & Bloom closes Ayurcann acquisition, adding Canadian cannabis brands, manufacturing capacity & national distribution to boost revenue and EBITDA.
-
NEW YORK, June 08, 2026 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. (“Aeries” or the “Company”) (Nasdaq: AERT), a global leader in Global Capability Center (“GCC”) services and business...
-
Potentially best-in-mechanism immunogenicity profile, with only 3.7% of participants developing antidrug antibodies Complete blockade of TL1A binding to DR3 for over 3 months expected at doses of 1...
-
Gastrointestinal prophylaxis reduced Grade ≥ 2 diarrhea/colitis from 55% without prophylaxis to 10% with prophylaxisThe maximum tolerated dose has not yet been determinedNo difference is observed in...
-
TORONTO, June 08, 2026 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE, TSX: MUX) (“McEwen” or the “Company”) is pleased to announce the results of the Pre-Feasibility Study (“PFS”) for its 100%-owned Grey...
-
Net Income improves by $5.2M and Adjusted EBITDA rises by $6.4M over prior year Gross Margin reaches 57.4%, an expansion of 540 basis points versus prior year Strong balance sheet with approximately...